Cat#:RP-0309H;Product Name:Recombinant Human CD300C / CMRF-35 / IGSF16 Protein (His Tag);Synonym:CLM-6,CMRF-35,CMRF-35A,CMRF35,CMRF35-A1,CMRF35A,CMRF35A1,IGSF16,LIR;Description:A DNA sequence encoding the human CD300C (NP_006669.1) extracellular domain (Met 1-Arg 183) was expressed, with a polyhistidine tag at the C-terminus.;Source:Human Cells;Predicted N Terminal:Met 29;Molecular Characterization:The recombinant human CD300C consists of 166 amino acids and predictes a molecular mass of 18.4 kDa. In SDS-PAGE under reducing conditions, the apparent molecular mass of rh CD300C is approximately 40-45 kDa due to glycosylation.;Purity:Greater than 95 % as determined by SDS-PAGE;Endotoxin:< 1.0 EU per ug of the protein as determined by the LAL method;Bioactivity:Please contact us for detailed information;Formulation:Lyophilized from sterile PBS, pH 7.4;Stability:Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃;Reconstitution:Please see related COA for specific instructions.;Storage:Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -70℃).;
A DNA sequence encoding the human CD300C (NP_006669.1) extracellular domain (Met 1-Arg 183) was expressed, with a polyhistidine tag at the C-terminus.
Source:
Human Cells
Predicted N Terminal:
Met 29
Molecular Characterization:
The recombinant human CD300C consists of 166 amino acids and predictes a molecular mass of 18.4 kDa. In SDS-PAGE under reducing conditions, the apparent molecular mass of rh CD300C is approximately 40-45 kDa due to glycosylation.
Purity:
Greater than 95 % as determined by SDS-PAGE
Endotoxin:
< 1.0 EU per ug of the protein as determined by the LAL method
Bioactivity:
Please contact us for detailed information
Formulation:
Lyophilized from sterile PBS, pH 7.4
Stability:
Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃
Reconstitution:
Please see related COA for specific instructions.
Storage:
Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -70℃).